501 related articles for article (PubMed ID: 29265047)
21. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
[TBL] [Abstract][Full Text] [Related]
22. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.
Connelly PJ; Lonergan M; Soto-Pedre E; Donnelly L; Zhou K; Pearson ER
Diabetes Obes Metab; 2017 Nov; 19(11):1579-1586. PubMed ID: 28432751
[TBL] [Abstract][Full Text] [Related]
23. [Proposal for the modification of metformin use in patients with chronic kidney disease].
Balogh Z; Mátyus J
Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
[TBL] [Abstract][Full Text] [Related]
24. Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2.
Altun E; Kaya B; Paydaş S; Sarıakçalı B; Karayaylalı I
Hemodial Int; 2014 Apr; 18(2):529-31. PubMed ID: 24299454
[TBL] [Abstract][Full Text] [Related]
25. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.
Lalau JD; Race JM
Drug Saf; 1999 Apr; 20(4):377-84. PubMed ID: 10230584
[TBL] [Abstract][Full Text] [Related]
26. [Chronic kidney diseases, metformin and lactic acidosis].
Borbély Z
Vnitr Lek; 2016 Apr; 62(4):299-303. PubMed ID: 27250607
[TBL] [Abstract][Full Text] [Related]
27. Occult metformin toxicity in three patients with profound lactic acidosis.
Perrone J; Phillips C; Gaieski D
J Emerg Med; 2011 Mar; 40(3):271-5. PubMed ID: 18571361
[TBL] [Abstract][Full Text] [Related]
28. Laboratory-Confirmed Metformin-Associated Lactic Acidosis.
Nestor C; Nasim S; Coyle N; Canavan C
Ir Med J; 2019 Sep; 112(8):992. PubMed ID: 31650826
[TBL] [Abstract][Full Text] [Related]
29. Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation.
Lalau JD; Azzoug ML; Kajbaf F; Briet C; Desailloud R
Diabetes Metab; 2014 Jun; 40(3):220-3. PubMed ID: 24417956
[TBL] [Abstract][Full Text] [Related]
30. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
[TBL] [Abstract][Full Text] [Related]
31. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
[TBL] [Abstract][Full Text] [Related]
32. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
[TBL] [Abstract][Full Text] [Related]
33. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
[TBL] [Abstract][Full Text] [Related]
34. [Metformin-associated lactic acidosis remains a serious complication of metformin therapy].
Orban JC; Giunti C; Levraut J; Grimaud D; Ichai C
Ann Fr Anesth Reanim; 2003 May; 22(5):461-5. PubMed ID: 12831973
[TBL] [Abstract][Full Text] [Related]
35. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
36. [Metformin-associated lactic acidosis in a patient with pre-existing risk factors].
Becker C; Luginbühl A; Pittl U; Schlienger R
Praxis (Bern 1994); 2005 Sep; 94(36):1402-7. PubMed ID: 16190374
[TBL] [Abstract][Full Text] [Related]
37. Metformin use in decompensated heart failure.
Boyd A; Nawarskas J
Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
[TBL] [Abstract][Full Text] [Related]
38. Metformin: time to review its role and safety in chronic kidney disease.
Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
[TBL] [Abstract][Full Text] [Related]
39. Metformin-associated lactic acidosis: case reports and literature review.
Chang CT; Chen YC; Fang JT; Huang CC
J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
[TBL] [Abstract][Full Text] [Related]
40. Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA.
Blumenberg A; Benabbas R; Sinert R; Jeng A; Wiener SW
J Med Toxicol; 2020 Apr; 16(2):222-229. PubMed ID: 31907741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
